Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study warns of ‘inadequate’ fertility policies in vet workplaces
Multiple respondents were under pressure to work even while actively miscarrying.
Over a fifth of respondents considered leaving their job as a result.

A new study has explored veterinary professionals’ workplace experiences with miscarriage, infertility and assisted fertility (MIAF).

In a cross-sectional survey, results revealed that over a fifth of respondents had left or considered leaving their job due to its approach to MIAF issues.

The online study saw 525 veterinary professionals describe 671 self-defined MIAF experiences from workplaces. It sought to investigate how their working environments and employers had impacted their experiences with MIAF.

Many of the responses to the survey described significant challenges with taking leave for MIAF-related situations.

Under practice policy, staff undergoing fertility treatments are typically permitted a maximum of three days leave for fertility appointments. This was not considered sufficient to complete investigations and treatments.

There also appeared to be a lack of transparency, with some respondents unaware whether their pay would be docked when they attended hospital appointments or that they would have to use sick leave.

Multiple respondents said they felt under pressure to remain at work in clinical practice, even while they were actively miscarrying.

Some did not even ask permission to leave work, due to concern for their job security and the workload they would leave behind. Meanwhile others had been told by managers that they could not leave until a coworker relieved them, or even that their time off was unnecessary.

Working during pregnancy loss was particularly common in cases of lone working, working out of hours, or ambulatory calls.

Where respondents were able to take leave after pregnancy loss, there was an absence of procedural policy. This meant that some respondents received daily messages from their workplace asking when they would be back.

Those who did work while pregnant found different challenges in avoiding anaesthetic drugs, radiation exposure, cytotoxic drugs and other physical hazards. Working only risk-assessed activities was particularly difficult for those lone working, short-staffed or working in large animal practice.

Researchers reflect that these experiences, and others, have had a profound impact on the mental health, wellbeing and workforce retention of veterinary practices. They have called for urgent action against inadequate policy, insufficient leave, and insensitive workplace communication.

The full study can be found in the journal VetRecord.

Image © PeopleImages/Shutterstock.com

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.